|
Quotes & Info
|
| VNDA > SEC Filings for VNDA > Form 8-K on 23-Jan-2013 | All Recent SEC Filings |
23-Jan-2013
Other Events, Financial Statements and Exhibits
On January 23, 2013, Vanda Pharmaceuticals Inc. issued a press release announcing the results from its RESET Phase III study. A copy of the press release is filed as Exhibit 99.1 hereto and incorporated by reference herein.
(d) Exhibits
Exhibit
No. Description
99.1 Press Release of Vanda Pharmaceuticals Inc. dated January 23, 2013.
|
|